tiprankstipranks
Trending News
More News >
Spyre Therapeutics, Inc (SYRE)
NASDAQ:SYRE
US Market

Compare Spyre Therapeutics (SYRE) vs. Competitors

Compare
500 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Spyre Therapeutics
$32.94
$2.49B
39.81%
7 Buy
0 Hold
0 Sell
Strong Buy
EyePoint Pharmaceuticals
$12.73
$1.02B
63.21%
5 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$305.62
$8.31B
-23.68
246.39%
13 Buy
1 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$9.67
$1.00B
-11.93
-24.16%
4 Buy
0 Hold
0 Sell
Strong Buy
Oculis Holding
$27.49
$1.51B
-10.91
21.64%
6 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$30.30
$1.59B
-11.38
188.25%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SYRE
Spyre Therapeutics
32.94
9.08
38.06%
EYPT
EyePoint Pharmaceuticals
12.73
6.11
92.30%
PRAX
Praxis Precision Medicines
305.62
218.21
249.64%
SPRY
ARS Pharmaceuticals
9.67
-3.13
-24.45%
OCS
Oculis Holding
27.49
5.39
24.39%
UPB
Upstream Bio, Inc.
26.00
17.47
204.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts